index,gene,ID,dBeta,feat.cgi,logFC,pathways
1,C1orf114,cg08047907,0.568073199118696,TSS200-island,0.505493391175351,
2,PGLYRP2,cg16206460,0.565326118661514,Body-island,0.462568216789756,
3,CLEC14A,cg05057720,0.511192699507276,1stExon-island,0.460665209544285,
4,ZNF177,cg09578475,0.508644086605246,TSS200-island,0.43698979688737,
5,NPTX2,cg18952796,0.507407215303772,5'UTR-island,0.432550142068455,
6,CSDAP1,cg15811515,0.502339452748216,TSS200-island,0.455347803550665,
7,GALR1,cg03502002,0.500378018863424,1stExon-island,0.481127309294986,['hsa04080:Neuroactive ligand-receptor interaction']
8,GPRC5B,cg07519235,0.499404292331997,5'UTR-island,0.474308493008814,
9,NKAPL,cg18675097,0.494569865182627,5'UTR-island,0.483103504041178,
10,LOXL1,cg10974980,0.492640940579663,Body-opensea,0.458629974900158,
11,CYP26A1,cg17538572,0.492409398304496,Body-island,0.461938999108169,
12,FOXE1,cg13791254,0.492265017661815,1stExon-island,0.415734016022735,
13,CALN1,cg17239236,0.489191404087586,5'UTR-island,0.474815561608459,
14,SIM1,cg27252696,0.486846004018308,TSS1500-island,0.395518135794269,
15,CCDC8,cg03576469,0.48458381206524,TSS200-shore,0.444145832820553,
16,FOXE3,cg22796507,0.480768910267305,1stExon-island,0.431500785149645,
17,MIR663,cg20395967,0.480747896295336,TSS1500-island,0.465722690578551,
18,DNM3,cg17154724,0.48049534502902,TSS1500-shore,0.469099282047341,['hsa04072:Phospholipase D signaling pathway']
19,NCOR2,cg00765705,0.479685749699441,Body-opensea,0.43202969752414,
20,ONECUT2,cg25547580,0.478756941783563,1stExon-island,0.45433527766114,
21,CD40,cg06571407,0.478103745355198,TSS200-island,0.447792519498717,"['hsa05202:Transcriptional misregulation in cancer', 'hsa04514:Cell adhesion molecules']"
22,PRKCB,cg03306374,0.477768033592346,1stExon-island,0.441992381253849,"['hsa05200:Pathways in cancer', 'hsa05206:MicroRNAs in cancer', 'hsa04020:Calcium signaling pathway', 'hsa04713:Circadian entrainment', 'hsa04921:Oxytocin signaling pathway', 'hsa04724:Glutamatergic synapse', 'hsa04723:Retrograde endocannabinoid signaling', 'hsa05225:Hepatocellular carcinoma', 'hsa05032:Morphine addiction', 'hsa04911:Insulin secretion', 'hsa04727:GABAergic synapse', 'hsa04972:Pancreatic secretion', 'hsa04971:Gastric acid secretion']"
23,MYO15B,cg08781140,0.477264831709821,Body-island,0.405042582926221,
24,SLITRK1,cg16727923,0.47656000316647,1stExon-island,0.470719632805798,['hsa04514:Cell adhesion molecules']
25,GRASP,cg06970510,0.474407529122243,Body-island,0.417880125433429,
26,SLC2A2,cg14777768,0.473985341502907,TSS1500-island,0.415471073068591,"['hsa04911:Insulin secretion', 'hsa04950:Maturity onset diabetes of the young', 'hsa04930:Type II diabetes mellitus']"
27,SLC7A14,cg21884231,0.47370285063272,5'UTR-island,0.434703381365056,
28,FOXA2,cg03774514,0.471647256525671,Body-island,0.408318763825624,['hsa04950:Maturity onset diabetes of the young']
29,TBX15,cg02177231,0.46759499471034,5'UTR-island,0.444415723503362,
30,MPZ,cg10896862,0.465126258034037,3'UTR-opensea,0.448676157559949,['hsa04514:Cell adhesion molecules']
31,TRH,cg01009664,0.464877693319972,5'UTR-island,0.431725922514328,['hsa04080:Neuroactive ligand-receptor interaction']
32,FOXD3,cg18279094,0.463617199663913,1stExon-island,0.420185204801043,
33,ZIC4,cg16768018,0.462099675499636,Body-island,0.433150278795785,
34,ANGPTL2,cg08076018,0.461529787918007,TSS200-opensea,0.371124311499369,
35,RYR2,cg07790615,0.460779740503983,TSS1500-island,0.451109518946878,"['hsa04024:cAMP signaling pathway', 'hsa04020:Calcium signaling pathway', 'hsa04713:Circadian entrainment', 'hsa04921:Oxytocin signaling pathway', 'hsa04911:Insulin secretion', 'hsa04972:Pancreatic secretion', 'hsa05412:Arrhythmogenic right ventricular cardiomyopathy']"
36,NXPH1,cg06335867,0.460515427073032,Body-island,0.442724347184617,
37,SLC6A3,cg14502484,0.460474665890593,TSS1500-island,0.398667176466633,
38,CLDN10,cg25032595,0.459546713198926,5'UTR-island,0.420854207951763,['hsa04514:Cell adhesion molecules']
39,SHF,cg18582992,0.459148899373328,Body-island,0.387716588353439,
40,BARHL2,cg11823511,0.458644543346452,TSS1500-island,0.403491031628128,
41,LHX1,cg14754787,0.457519626214599,Body-island,0.408773438195637,
42,ACTL6B,cg24471254,0.456692917985476,Body-island,0.410154336389551,['hsa05225:Hepatocellular carcinoma']
43,SSTR1,cg23248887,0.456163982342781,Body-island,0.424105508454312,"['hsa04080:Neuroactive ligand-receptor interaction', 'hsa04024:cAMP signaling pathway']"
44,NCALD,cg00680551,0.454122358781129,5'UTR-shore,0.446354034842574,
45,GNG4,cg09649610,0.453273441365835,TSS1500-island,0.441704617597355,"['hsa05200:Pathways in cancer', 'hsa04151:PI3K-Akt signaling pathway', 'hsa04713:Circadian entrainment', 'hsa04724:Glutamatergic synapse', 'hsa04723:Retrograde endocannabinoid signaling', 'hsa05032:Morphine addiction', 'hsa04727:GABAergic synapse']"
46,SCG5,cg12134633,0.453102432745624,5'UTR-opensea,0.408361001485416,
47,CFTR,cg00735923,0.453063112508108,TSS200-opensea,0.44321173671872,"['hsa04024:cAMP signaling pathway', 'hsa04972:Pancreatic secretion', 'hsa04971:Gastric acid secretion']"
48,TMEM145,cg11957331,0.449916961176551,Body-island,0.445792205830479,
49,ENPP2,cg06998282,0.44969145270457,TSS1500-opensea,0.442635238834858,
50,CA3,cg18674980,0.449596431284312,TSS1500-shore,0.416777896743634,
51,ITIH5,cg10119075,0.449392046780225,TSS1500-opensea,0.428135149689964,
52,PRKAR1B,cg23605961,0.448734488677701,5'UTR-shore,0.425989421052071,
53,FERD3L,cg25691167,0.44829013548663,1stExon-island,0.436676108897297,
54,COX7A1,cg24335895,0.44779796448361,TSS200-shore,0.423381274930283,
55,SOX1,cg24604013,0.447486232619253,TSS1500-island,0.428207362042092,
56,MOBKL2C,cg06760830,0.447425202568504,Body-shore,0.413791677945919,
57,PODN,cg04765848,0.446917884968203,TSS1500-island,0.422059781742728,
58,NID2,cg22881914,0.446659199375131,TSS1500-island,0.436515219743878,
59,GLI2,cg13713922,0.446561632962932,Body-shore,0.419113025674376,"['hsa05200:Pathways in cancer', 'hsa04390:Hippo signaling pathway']"
60,ADAMTS20,cg19619405,0.446403634584365,TSS200-island,0.440651502993493,
61,TNR,cg24932457,0.446300455475426,5'UTR-island,0.41093880536833,"['hsa05206:MicroRNAs in cancer', 'hsa04151:PI3K-Akt signaling pathway']"
62,OTX2OS1,cg21039708,0.446157707955855,TSS1500-island,0.4297825795555,
63,ZNF454,cg17840719,0.446107942590563,1stExon-island,0.431096463781173,
64,DPP6,cg06495961,0.445848592419798,1stExon-island,0.430221861268763,
65,SNX18,cg26118943,0.445757223165523,1stExon-shore,0.392937614549653,
66,VGLL4,cg27083087,0.445017693242916,Body-island,0.408962996845731,
67,NKX2-1,cg23906738,0.442994940860537,Body-island,0.431143288235771,
68,PDE4B,cg22488256,0.442904450390508,TSS200-shore,0.421481821665457,"['hsa04024:cAMP signaling pathway', 'hsa05032:Morphine addiction']"
69,ANKRD35,cg01000615,0.442558511874873,Body-opensea,0.353818317862987,
70,MIR129-2,cg14416371,0.441452448023853,TSS200-island,0.437898479374797,['hsa05206:MicroRNAs in cancer']
71,TBKBP1,cg10024583,0.440802719397213,1stExon-island,0.415463262962322,
72,NPAS4,cg14699728,0.439866490401482,5'UTR-island,0.419415938637354,
73,CUEDC1,cg07665510,0.439723220002096,Body-opensea,0.381628644429135,
74,TAC1,cg17437939,0.439357992274703,TSS200-island,0.424010961420512,['hsa04080:Neuroactive ligand-receptor interaction']
75,TLX1,cg14861089,0.439337372260202,Body-island,0.43026042191954,['hsa05202:Transcriptional misregulation in cancer']
76,FOXQ1,cg26422161,0.43919802066895,1stExon-island,0.420325321445666,
77,PTPRN,cg03970036,0.439130180404336,TSS200-island,0.433110699540801,
78,MIR124-2,cg07792478,0.438057773994151,TSS1500-island,0.42585769709098,['hsa05206:MicroRNAs in cancer']
79,DAB2,cg12290311,0.437089518487052,5'UTR-shore,0.38020015640819,
80,SOX17,cg08044097,0.436589115008254,Body-island,0.405469808529095,
81,ASPG,cg20965743,0.436363475201307,Body-island,0.381761353264744,
82,NETO1,cg18651870,0.436187444371456,TSS200-island,0.396860200989928,
83,NR5A2,cg04097639,0.436163223705197,Body-island,0.426623986931455,
84,RGS22,cg24848035,0.435927812613453,TSS200-island,0.420707142949045,
85,MTMR9L,cg16985778,0.435796811743267,TSS1500-shore,0.398416860288813,
86,LHX4,cg09671258,0.435534851901144,Body-island,0.423234951117503,
87,OTX1,cg07974511,0.434403748033318,Body-island,0.393210895713971,
88,PHACTR1,cg13246235,0.433343845089738,Body-island,0.386869679616827,
89,SSPO,cg07703462,0.432638095340222,Body-island,0.42266368803449,
90,MMP9,cg26132320,0.432132767037326,Body-island,0.421482273882419,"['hsa05200:Pathways in cancer', 'hsa05206:MicroRNAs in cancer', 'hsa05202:Transcriptional misregulation in cancer']"
91,CACNG7,cg08393317,0.43208868672701,Body-island,0.421662223260771,"['hsa04921:Oxytocin signaling pathway', 'hsa05412:Arrhythmogenic right ventricular cardiomyopathy']"
92,RPTOR,cg04191427,0.432002963096689,Body-shore,0.410106267743372,"['hsa05206:MicroRNAs in cancer', 'hsa04151:PI3K-Akt signaling pathway']"
93,ATP5G2,cg16264705,0.431605455239048,TSS1500-island,0.369598061073661,
94,RTN4RL1,cg14769786,0.431314993125472,Body-shore,0.400952306360778,
95,EFR3B,cg07074666,0.430664781271325,Body-island,0.41624867552935,
96,LOC134466,cg05016408,0.430481518883763,TSS200-island,0.42464223428572,
97,SYNPO2L,cg12317414,0.430172401600471,Body-shore,0.398025221254535,
98,LTBP2,cg27317046,0.430163462649232,Body-opensea,0.382674011535004,
99,RUSC1,cg22877509,0.429863226846098,TSS200-island,0.399436113400569,
100,GABRG2,cg03886192,0.429515752861919,1stExon-opensea,0.425797855750646,"['hsa04080:Neuroactive ligand-receptor interaction', 'hsa04723:Retrograde endocannabinoid signaling', 'hsa05032:Morphine addiction', 'hsa04727:GABAergic synapse', 'hsa05033:Nicotine addiction']"
101,PDE4C,cg15215348,0.429355919015594,5'UTR-shore,0.413904548704779,"['hsa04024:cAMP signaling pathway', 'hsa05032:Morphine addiction']"
102,SIX6,cg13019491,0.42934354688025,Body-island,0.396739431985172,
103,NEFM,cg23290344,0.428850076560134,TSS1500-island,0.392328572557537,
104,TTBK1,cg16620382,0.428638615015168,TSS200-island,0.414749341995801,
105,MXRA7,cg13387113,0.428552286888901,Body-opensea,0.403695265372632,
106,PRDM13,cg17302155,0.428515352478581,Body-island,0.412235581245865,
107,LOC284798,cg04299389,0.428410652635258,Body-island,0.375453550435474,
108,BCAS3,cg10588135,0.428366087390718,Body-opensea,0.395262768185477,
109,C2orf55,cg19043574,0.428264534539567,Body-island,0.400145433142423,
110,TDRD10,cg18081940,0.428129697028948,5'UTR-island,0.381344502103016,
111,CUX1,cg06173663,0.428116722764184,Body-opensea,0.41599776930526,
112,CPXM1,cg07113642,0.427758634954488,5'UTR-island,0.408367216562859,
113,TRIM46,cg15497761,0.426329697262643,Body-island,0.376592717015353,
114,KIF21B,cg07561747,0.425709183361156,Body-opensea,0.384618248024164,
115,DBX1,cg13445796,0.425530704058823,1stExon-island,0.421915044709357,
116,KCNE3,cg04574090,0.425523955243713,TSS200-island,0.408851471778372,
117,GLT1D1,cg00901320,0.425187470908858,Body-island,0.413942114141369,
118,ST7,cg00764217,0.424934381697148,Body-opensea,0.37883805572651,
119,COL11A2,cg08481075,0.424805678555589,TSS1500-island,0.420844337501617,
120,MAST1,cg26870725,0.424663185918493,Body-shore,0.377996332849633,
121,HFE2,cg19624849,0.424624778046088,5'UTR-island,0.375123042138926,
122,HCK,cg17508991,0.423538120395618,TSS1500-shore,0.399611325103253,
123,HPCAL4,cg18438793,0.42343689572549,Body-island,0.414509902762248,
124,ADCY4,cg23179456,0.422951975971897,TSS200-island,0.394950660057071,"['hsa05200:Pathways in cancer', 'hsa04024:cAMP signaling pathway', 'hsa04020:Calcium signaling pathway', 'hsa04713:Circadian entrainment', 'hsa04921:Oxytocin signaling pathway', 'hsa04724:Glutamatergic synapse', 'hsa04723:Retrograde endocannabinoid signaling', 'hsa05032:Morphine addiction', 'hsa04911:Insulin secretion', 'hsa04072:Phospholipase D signaling pathway', 'hsa04727:GABAergic synapse', 'hsa04972:Pancreatic secretion', 'hsa04971:Gastric acid secretion']"
125,ELTD1,cg15084543,0.422855912203794,5'UTR-island,0.410304015474063,
126,BCAT1,cg20399616,0.422694011113261,Body-island,0.403384699228205,
127,ZNF709,cg22637867,0.422569176501159,5'UTR-island,0.411242579683123,
128,RGS2,cg05374271,0.422406369284662,Body-shore,0.351126643834303,['hsa04921:Oxytocin signaling pathway']
129,SRRM4,cg15341350,0.42207469023878,Body-opensea,0.40535663225214,
130,PARP15,cg19166302,0.421817559243014,1stExon-island,0.415661595217001,
131,PCDH17,cg26444528,0.421659145538017,1stExon-island,0.416290624062387,
132,RGS17,cg17264670,0.421596730581344,TSS1500-island,0.401706164888273,
133,EPHA10,cg21306240,0.421418290484638,TSS200-island,0.41358734084762,
134,RCN3,cg21941030,0.421128708514422,1stExon-island,0.412099129045011,
135,CACNA1B,cg05863502,0.420555561847159,TSS1500-island,0.388543111599927,"['hsa04020:Calcium signaling pathway', 'hsa04723:Retrograde endocannabinoid signaling', 'hsa05032:Morphine addiction', 'hsa04727:GABAergic synapse', 'hsa05033:Nicotine addiction', 'hsa04930:Type II diabetes mellitus']"
136,TTYH3,cg17550566,0.420406877847557,Body-opensea,0.357737626046659,
137,ZFP42,cg06274159,0.420303432273887,TSS200-island,0.401158337553033,
138,RARRES2,cg27494647,0.419924336562229,TSS200-island,0.411156702744321,
139,MGC14436,cg08141615,0.419039511799126,Body-opensea,0.400058791999574,
140,SALL3,cg10717463,0.418723111005797,Body-island,0.380147276565044,
141,CTSA,cg08260891,0.418620223135173,TSS1500-shore,0.394371158294983,
142,HOXD9,cg22674699,0.418510841905769,1stExon-island,0.389222578340438,
143,SLC38A4,cg11146691,0.418474741754862,1stExon-opensea,0.391266105273833,
144,KCNK9,cg04849842,0.417520879552932,Body-island,0.400523573708045,
145,GAL3ST3,cg24960947,0.417440759586829,5'UTR-island,0.417440759586829,
146,SALL2,cg00800229,0.417014432897275,1stExon-opensea,0.401964340290399,
147,WNK4,cg08409113,0.41682173766685,Body-island,0.399484644258,
148,FEZF2,cg20072171,0.416587877944243,Body-island,0.408842362533201,
149,TMEM196,cg04111071,0.416548196481257,TSS1500-shore,0.397403076111624,
150,PITX2,cg05835105,0.416482823324621,Body-island,0.410705560324418,
151,GCK,cg13476133,0.416435632806495,Body-island,0.408784630044514,"['hsa04911:Insulin secretion', 'hsa04950:Maturity onset diabetes of the young', 'hsa04930:Type II diabetes mellitus']"
152,L1TD1,cg23049458,0.416197771999627,5'UTR-island,0.412237006055541,
153,C14orf23,cg23302649,0.415999116538747,Body-island,0.395554142140403,
154,SEZ6L2,cg27267227,0.415970024518938,Body-island,0.396893711232081,
155,ZNF540,cg03975694,0.415926449218356,5'UTR-shelf,0.398355441574876,
156,ADORA3,cg14669379,0.415591024328444,Body-island,0.376260187550736,['hsa04080:Neuroactive ligand-receptor interaction']
157,SALL1,cg01146232,0.414785832113489,TSS1500-island,0.400712633908324,
158,ZFP106,cg06794543,0.414264031757071,TSS200-opensea,0.380394841470574,
159,ZNF560,cg05221167,0.413682945375825,TSS200-shore,0.407098569154396,
160,OPCML,cg18710784,0.413429345313106,TSS1500-island,0.408428725056447,
161,ZMIZ1,cg04007726,0.413275697879369,Body-opensea,0.395214985620126,
162,NPHS2,cg08229358,0.413247677602136,1stExon-island,0.405433414947849,
163,TMEM132C,cg00579520,0.413045667264925,Body-island,0.405613763271739,
164,CDH4,cg07198552,0.412855358497515,Body-island,0.402729379438192,['hsa04514:Cell adhesion molecules']
165,PENK,cg04127342,0.412351833208696,Body-island,0.387852388021428,['hsa04080:Neuroactive ligand-receptor interaction']
166,RNF11,cg09941363,0.412249479493525,Body-opensea,0.356575084455889,
167,POU4F2,cg06083330,0.412189648772928,Body-island,0.405505932474048,
168,SEMA4A,cg05047401,0.411672200263456,Body-opensea,0.402411393367032,
169,GRIA1,cg08578734,0.411500024181524,1stExon-opensea,0.399724826103878,"['hsa04080:Neuroactive ligand-receptor interaction', 'hsa04024:cAMP signaling pathway', 'hsa04713:Circadian entrainment', 'hsa04724:Glutamatergic synapse', 'hsa04723:Retrograde endocannabinoid signaling', 'hsa05033:Nicotine addiction']"
170,TULP1,cg24281267,0.411132116573972,Body-island,0.403937654453259,
171,RNF220,cg10224098,0.411061434737591,5'UTR-island,0.4035005374402,
172,CNGA3,cg19370054,0.410860501689898,5'UTR-island,0.391032744605406,['hsa04024:cAMP signaling pathway']
173,HOXA4,cg07317062,0.410735597300033,5'UTR-island,0.399969768855326,
174,LHX2,cg14425564,0.410484843739873,Body-opensea,0.37574000669349,
175,LEP,cg00840332,0.41012838648545,TSS200-island,0.389477735591641,['hsa04080:Neuroactive ligand-receptor interaction']
176,C1QL3,cg08949408,0.409934443171643,Body-island,0.386641155013611,
177,GRM6,cg00582971,0.409883565182281,TSS200-island,0.402613423665516,"['hsa04080:Neuroactive ligand-receptor interaction', 'hsa04724:Glutamatergic synapse', 'hsa04072:Phospholipase D signaling pathway']"
178,SSTR4,cg07676859,0.409776066747849,TSS200-island,0.398808770557778,['hsa04080:Neuroactive ligand-receptor interaction']
179,GYPC,cg25390440,0.409671797959545,TSS1500-shore,0.391717919623299,
180,AFAP1L1,cg09651145,0.409494802864647,TSS1500-island,0.384118510010471,
181,PXK,cg09627520,0.409406974124118,3'UTR-opensea,0.381484029434077,
182,HOXA9,cg26521404,0.409320470185862,1stExon-island,0.375000853984416,['hsa05202:Transcriptional misregulation in cancer']
183,ITPKA,cg08680048,0.409270341660259,Body-island,0.399700408694294,['hsa04020:Calcium signaling pathway']
184,C19orf41,cg10374084,0.40901995482849,1stExon-island,0.399738986463169,
185,BTBD3,cg05822633,0.408704831059251,5'UTR-opensea,0.390510064165947,
186,ZIC1,cg04738965,0.40868624978268,1stExon-island,0.379420626159027,
187,DLEU7,cg17241776,0.408382765294701,1stExon-island,0.398666917418518,
188,LHX8,cg08146483,0.408375203410982,Body-island,0.399904625155726,
189,TGFBR3,cg17080882,0.408369975488772,Body-opensea,0.358207691630228,
190,GSTA4,cg15925365,0.408231463087781,Body-shore,0.355466415020004,"['hsa05200:Pathways in cancer', 'hsa05225:Hepatocellular carcinoma']"
191,CADPS,cg15957055,0.408117252268167,5'UTR-island,0.386806855302066,
192,ADAMTS12,cg26573704,0.408026455075554,TSS200-island,0.38962021208279,
193,CYTL1,cg01114088,0.407534962921092,1stExon-island,0.388458427007049,
194,RGS20,cg03348397,0.407497962959062,Body-island,0.402456380688495,
195,MAGI2,cg01158680,0.407394677156995,TSS1500-shore,0.394756409988252,['hsa04151:PI3K-Akt signaling pathway']
196,PCDHGA4,cg23244790,0.407106060385522,Body-island,0.401926108813699,
197,TBC1D23,cg09439920,0.406999323564014,TSS1500-shore,0.392068391932015,
198,ADAMTS16,cg22784954,0.406545475616121,1stExon-island,0.382157803119241,
199,ACCN1,cg24613080,0.406313560473682,TSS1500-island,0.362456857551726,
200,DOCK2,cg08862890,0.406195338130096,Body-island,0.399363536956823,
201,FLRT2,cg01537995,0.406090974441298,TSS200-shore,0.393897964019447,
202,NT5E,cg13315970,0.405959578898466,TSS200-shore,0.385290333988672,
203,FMN2,cg15031661,0.405572536308521,1stExon-island,0.398070296682226,
204,OTX2,cg13023623,0.405482470978918,5'UTR-island,0.390001819704703,
205,SOX2OT,cg05513806,0.404847670584385,Body-shore,0.398420882997734,
206,WT1,cg10244666,0.404255433009982,Body-opensea,0.384521281348115,['hsa05202:Transcriptional misregulation in cancer']
207,PFN3,cg06847624,0.40391639574751,TSS200-island,0.382598684263667,
208,PAX6,cg18372607,0.4036397594748,Body-shore,0.379420587916994,['hsa04950:Maturity onset diabetes of the young']
209,HOPX,cg21899596,0.403477088767962,1stExon-island,0.396923577969035,
210,IGFBP4,cg03635766,0.403412491321449,Body-opensea,0.37825529667685,
211,OXT,cg12099952,0.403408819288992,Body-island,0.399352360959363,"['hsa04080:Neuroactive ligand-receptor interaction', 'hsa04024:cAMP signaling pathway', 'hsa04921:Oxytocin signaling pathway']"
212,ACOT11,cg10266490,0.403402408381878,TSS200-opensea,0.367619372562234,
213,C21orf57,cg02776659,0.403398071636626,Body-island,0.365542565109671,
214,WBSCR17,cg03044249,0.403176175058197,TSS1500-island,0.389093506903159,
215,OLIG3,cg01972751,0.403093429457662,1stExon-island,0.397316382632391,
216,SFRP2,cg05164933,0.403011258573173,TSS200-island,0.390045723173948,
217,ZIC5,cg20985450,0.402938220763776,Body-island,0.394113207734996,
218,ZNF660,cg22598028,0.402876260581831,5'UTR-island,0.395177744206228,
219,USP44,cg07783282,0.402763182562359,TSS1500-island,0.400032433522817,
220,SEPW1,cg07953015,0.402726025091821,3'UTR-shelf,0.372909333287933,
221,VSTM2B,cg04711162,0.402397095167168,1stExon-island,0.385434216064583,
222,HTR6,cg27549720,0.402053612031965,5'UTR-island,0.381410885296401,"['hsa04080:Neuroactive ligand-receptor interaction', 'hsa04024:cAMP signaling pathway', 'hsa04020:Calcium signaling pathway']"
223,ZSCAN18,cg14231297,0.401590812265571,TSS200-island,0.393594478382049,
224,TXNRD1,cg05741937,0.401567277917783,Body-island,0.382888211860379,"['hsa05200:Pathways in cancer', 'hsa05225:Hepatocellular carcinoma']"
225,CYTH2,cg01532436,0.401478898384901,3'UTR-island,0.374667646143599,['hsa04072:Phospholipase D signaling pathway']
226,ID4,cg23165899,0.4013927290571,TSS1500-island,0.383390897255855,
227,ARHGAP23,cg03930313,0.400764653727175,Body-island,0.367632570717665,
228,C17orf93,cg12374721,0.400729781831427,TSS1500-shore,0.389604888104569,
229,PTPRN2,cg04059568,0.399574957624159,Body-island,0.390479222499407,
230,LUZP1,cg26530485,0.399396980167493,TSS1500-opensea,0.373975238401883,
231,GRIN1,cg13759674,0.399291729039827,Body-island,0.385595435430681,"['hsa04080:Neuroactive ligand-receptor interaction', 'hsa04024:cAMP signaling pathway', 'hsa04020:Calcium signaling pathway', 'hsa04713:Circadian entrainment', 'hsa04724:Glutamatergic synapse', 'hsa05033:Nicotine addiction']"
232,VAX1,cg08833577,0.399034265362434,TSS1500-island,0.387924194229467,
233,ARL3,cg06361405,0.398821877292072,3'UTR-opensea,0.385888183618541,
234,CRHBP,cg04306063,0.398597021388255,Body-island,0.389335246516594,
235,NR1I2,cg12702981,0.398561600940032,Body-shore,0.380878769529217,
236,EFHA2,cg12097222,0.398190039533963,1stExon-island,0.378182805865213,
237,FAT4,cg17265829,0.398184418092894,1stExon-island,0.389202577445487,
238,TACC1,cg14284618,0.398148213185473,5'UTR-opensea,0.385645961232884,
239,FOXG1,cg07489048,0.398116529317727,1stExon-island,0.368260213673933,
240,SIX3,cg00097146,0.398051456937887,Body-island,0.365230999054454,
241,LOC100192378,cg22538780,0.398003084824554,Body-opensea,0.374201457826134,
242,ANKMY1,cg16909733,0.397827912106721,Body-island,0.385997802769615,
243,AHNAK,cg25272143,0.397826234997559,Body-island,0.3773575954424,
244,HOXD8,cg09238180,0.39754514656139,TSS1500-island,0.392005186001116,
245,ALX3,cg06215569,0.397535705439633,Body-island,0.363424995316632,
246,GRM1,cg08958294,0.397115203892999,5'UTR-shore,0.393635286869438,"['hsa04080:Neuroactive ligand-receptor interaction', 'hsa04020:Calcium signaling pathway', 'hsa04724:Glutamatergic synapse', 'hsa04723:Retrograde endocannabinoid signaling', 'hsa04072:Phospholipase D signaling pathway']"
247,CIT,cg24973993,0.396548227113521,Body-shore,0.362773430666712,
248,LOC643719,cg23200020,0.396323592097802,Body-island,0.386650515708496,
249,SSH1,cg19256314,0.396265452542223,Body-opensea,0.359758904120989,
250,CHST2,cg17373442,0.396255217961766,Body-island,0.379563097939841,
251,WNT3A,cg26841013,0.395940407054705,3'UTR-shore,0.386624296353716,"['hsa05200:Pathways in cancer', 'hsa05206:MicroRNAs in cancer', 'hsa05225:Hepatocellular carcinoma', 'hsa04390:Hippo signaling pathway']"
252,TGFB2,cg07810039,0.395916122079943,Body-opensea,0.395916122079943,"['hsa05200:Pathways in cancer', 'hsa05206:MicroRNAs in cancer', 'hsa05225:Hepatocellular carcinoma', 'hsa04390:Hippo signaling pathway']"
253,PCDHB19P,cg17514558,0.395853481831726,Body-island,0.378279674874919,
254,VWC2,cg01893212,0.395783097316872,TSS200-island,0.38178646458025,
255,SST,cg02164046,0.395107101945822,1stExon-island,0.381828853200487,"['hsa04080:Neuroactive ligand-receptor interaction', 'hsa04024:cAMP signaling pathway', 'hsa04971:Gastric acid secretion']"
256,LBXCOR1,cg27649239,0.394283102085591,Body-island,0.39113008004796,
257,CRMP1,cg03544320,0.393826578436399,1stExon-island,0.376826631078016,
258,FLJ32063,cg10168149,0.393821340997665,Body-island,0.385123663229712,
259,AHRR,cg03604011,0.393768616008904,Body-opensea,0.382363114794951,
260,KIAA1614,cg02156380,0.393748964993728,Body-island,0.359995444813541,
261,FGF18,cg07100000,0.393301977922927,Body-island,0.37913884877049,"['hsa05200:Pathways in cancer', 'hsa04020:Calcium signaling pathway', 'hsa04151:PI3K-Akt signaling pathway']"
262,IGF2BP1,cg02745847,0.393102536527161,Body-island,0.359979758801934,['hsa05206:MicroRNAs in cancer']
263,PPP1R7,cg16751493,0.392865398194769,Body-opensea,0.353644750298973,
264,WDR8,cg04021697,0.392827290913207,TSS1500-island,0.38179857643064,
265,CAV2,cg16260298,0.392803802423192,Body-island,0.379539510809335,
266,INA,cg24680586,0.392761351435696,TSS200-island,0.383966808259155,
267,HOXD10,cg10364040,0.392741738130511,TSS1500-island,0.387455297882494,['hsa05206:MicroRNAs in cancer']
268,PRDM14,cg13267264,0.392551288268383,TSS200-island,0.387225940384719,
269,CCND2,cg13391820,0.39248471569682,Body-island,0.368544661253032,"['hsa05200:Pathways in cancer', 'hsa05206:MicroRNAs in cancer', 'hsa04151:PI3K-Akt signaling pathway', 'hsa05202:Transcriptional misregulation in cancer', 'hsa04390:Hippo signaling pathway']"
270,CDK6,cg07469637,0.392345439826959,TSS1500-island,0.384329691049917,"['hsa05200:Pathways in cancer', 'hsa05206:MicroRNAs in cancer', 'hsa04151:PI3K-Akt signaling pathway', 'hsa05225:Hepatocellular carcinoma']"
271,TCTEX1D1,cg25339566,0.392215589469367,5'UTR-island,0.383180265521958,
272,NXPH2,cg00697992,0.392188122119808,Body-shore,0.379654174492878,
273,ITPRIPL1,cg24161793,0.391934818974653,TSS1500-shore,0.375746797453067,
274,NOL4,cg14002960,0.391215360762876,Body-island,0.365380049547055,
275,PDPN,cg18877506,0.390784784237588,TSS1500-island,0.379397464835635,
276,NKX6-2,cg11174855,0.390384929743354,3'UTR-island,0.382013648854828,
277,PPP1R13L,cg07517893,0.390034535183249,Body-island,0.363697353321732,
278,GPRIN1,cg02098752,0.389969421005084,Body-island,0.3621858162474,
279,NBEAL2,cg02534363,0.389871082347112,3'UTR-island,0.35948779160401,
280,MAP3K11,cg19811337,0.389848520432796,Body-shore,0.376425282621115,
281,PCDH8,cg27360326,0.38968851986925,1stExon-island,0.382553148150251,
282,EVC2,cg06426416,0.389623937536223,5'UTR-island,0.361150703761074,
283,ST8SIA3,cg13096208,0.389431604223118,1stExon-island,0.3792507787539,
284,SCRT2,cg01235820,0.389422845135467,3'UTR-island,0.380108993879221,
285,GPR25,cg13300273,0.389391566621944,1stExon-island,0.364238182275143,
286,PLTP,cg24182521,0.388993597677069,TSS1500-shore,0.358016061913389,
287,NEUROD1,cg06714480,0.388618708445384,5'UTR-shelf,0.377818803888111,['hsa04950:Maturity onset diabetes of the young']
288,LIX1L,cg04846710,0.388473416329119,Body-shore,0.38264945482775,
289,NPY,cg05158615,0.388179070466259,TSS1500-island,0.377358600508464,"['hsa04080:Neuroactive ligand-receptor interaction', 'hsa04024:cAMP signaling pathway']"
290,COL16A1,cg23305408,0.387906014475998,1stExon-island,0.376141045409703,
291,CACNG8,cg24415208,0.387731640430345,1stExon-island,0.38335876175577,"['hsa04921:Oxytocin signaling pathway', 'hsa05412:Arrhythmogenic right ventricular cardiomyopathy']"
292,LPAR5,cg25136495,0.387608169504603,Body-island,0.379024836715281,"['hsa05200:Pathways in cancer', 'hsa04151:PI3K-Akt signaling pathway', 'hsa04072:Phospholipase D signaling pathway']"
293,C17orf64,cg09695735,0.387304895308671,TSS1500-island,0.376769117392864,
294,C1orf94,cg16348470,0.387241840809569,5'UTR-island,0.378589717157186,
295,SCT,cg25774643,0.387055340252695,TSS200-island,0.360931843329705,"['hsa04080:Neuroactive ligand-receptor interaction', 'hsa04972:Pancreatic secretion']"
296,EOMES,cg15540820,0.386713974552532,TSS1500-island,0.386713974552532,
297,ZNF232,cg27362525,0.386294920417925,5'UTR-island,0.386294920417925,
298,KRCC1,cg12691004,0.385863240222827,5'UTR-shore,0.379953289949469,
299,SGIP1,cg00460049,0.385499317425573,TSS1500-island,0.374715100174126,
300,HOXC4,cg07080050,0.385471131199935,5'UTR-island,0.359597844654126,
301,NKX3-2,cg12973941,0.385382358710944,1stExon-island,0.355741662614285,
302,HOXA10,cg14625175,0.385336925661679,TSS200-island,0.385336925661679,['hsa05202:Transcriptional misregulation in cancer']
303,FGF8,cg06169131,0.38528034155448,TSS1500-island,0.368961325383047,"['hsa05200:Pathways in cancer', 'hsa04020:Calcium signaling pathway', 'hsa04151:PI3K-Akt signaling pathway']"
304,GCM2,cg05452406,0.385173494031719,Body-island,0.378275461576339,
305,SEMA6C,cg26331172,0.385157126617736,5'UTR-island,0.369923059751711,
306,ADCYAP1,cg11859607,0.385062166319356,Body-island,0.381073026738379,"['hsa04080:Neuroactive ligand-receptor interaction', 'hsa04024:cAMP signaling pathway', 'hsa04713:Circadian entrainment', 'hsa04911:Insulin secretion']"
307,DMRTA2,cg17800654,0.384935354414565,5'UTR-island,0.369837151190013,
308,ZSCAN1,cg25648436,0.384621743195136,Body-island,0.366102222539077,
309,PAX5,cg13482308,0.384178392899779,Body-island,0.376170830478041,['hsa05202:Transcriptional misregulation in cancer']
310,ANKRD53,cg15165122,0.384169122119555,Body-island,0.35149955084288,
311,NKX2-8,cg18396984,0.384061201932078,3'UTR-island,0.379047921189289,
312,ACVR1,cg09499849,0.383661303233327,5'UTR-opensea,0.353229900437718,
313,C12orf42,cg27663938,0.383576535603094,Body-island,0.377941144799901,
314,BNC1,cg09180848,0.383298203286824,TSS1500-island,0.364338944235896,
315,CACHD1,cg24306340,0.382955960679434,Body-shore,0.373832620507973,
316,PAX2,cg04436818,0.382877971101449,3'UTR-shore,0.375798387419746,
317,IRF4,cg06392169,0.382535272449093,5'UTR-island,0.358836931498914,
318,IGLON5,cg15985184,0.38200881786454,Body-island,0.374281803184606,
319,NFIL3,cg07084627,0.38190480205482,5'UTR-island,0.381904802054819,
320,POU3F3,cg19513834,0.381820774953301,TSS1500-island,0.378526113133151,
321,EGFLAM,cg15182643,0.381708105954908,TSS1500-shore,0.366442182401426,
322,LRRC34,cg08193579,0.381543213126728,Body-shore,0.370541793688151,
323,DBC1,cg03625109,0.381439911746953,TSS1500-island,0.381439911746953,
324,NOX4,cg12161228,0.38141428955397,1stExon-island,0.359946621900845,
325,C1orf157,cg19366877,0.381340321806328,TSS1500-opensea,0.350702946643026,
326,ZNF521,cg21183523,0.381336495719717,Body-shore,0.371748312134979,
327,TSPAN10,cg18268547,0.381260079039182,3'UTR-island,0.356372980227543,
328,BDNF,cg11718030,0.381226283163505,TSS1500-island,0.360191556804479,"['hsa04024:cAMP signaling pathway', 'hsa04151:PI3K-Akt signaling pathway']"
329,C14orf39,cg23989821,0.380847576265888,5'UTR-island,0.376843139395552,
330,PRLHR,cg20624923,0.380835282973276,TSS1500-island,0.368144477682221,['hsa04080:Neuroactive ligand-receptor interaction']
331,RGS12,cg19974227,0.3807973157411,Body-shelf,0.3807973157411,
332,VSTM2A,cg21179088,0.38079379555595,Body-island,0.360101763637156,
333,MYF6,cg05860723,0.380485986646361,Body-island,0.361415314655606,
334,TIMP2,cg05306745,0.380270215834352,TSS1500-island,0.367844419589127,
335,A2BP1,cg00590139,0.380220572499325,Body-shore,0.371264975471016,
336,C12orf68,cg15959252,0.380199188464155,3'UTR-shore,0.365034455274887,
337,CNTNAP5,cg08523865,0.380039383972275,TSS1500-island,0.370660232818182,
338,GABRA4,cg24394172,0.379714437335938,Body-island,0.364669395927574,"['hsa04080:Neuroactive ligand-receptor interaction', 'hsa04723:Retrograde endocannabinoid signaling', 'hsa05032:Morphine addiction', 'hsa04727:GABAergic synapse', 'hsa05033:Nicotine addiction']"
339,DSC3,cg11814235,0.379666471708881,Body-island,0.366602092929182,
340,PDX1,cg26299169,0.379490269668749,3'UTR-island,0.375779137147571,"['hsa04911:Insulin secretion', 'hsa04950:Maturity onset diabetes of the young', 'hsa04930:Type II diabetes mellitus']"
341,CRYM,cg16596604,0.379361931673724,5'UTR-shore,0.379361931673724,
342,CLDN6,cg02732252,0.37919056514095,5'UTR-island,0.358731595358991,['hsa04514:Cell adhesion molecules']
343,RECK,cg12717594,0.378610225149665,Body-island,0.362465210912033,['hsa05206:MicroRNAs in cancer']
344,LHFPL4,cg04061117,0.378460522556244,5'UTR-shore,0.370082696524175,
345,SLC24A4,cg18229521,0.378208518522984,1stExon-island,0.370349673874793,
346,ATP4A,cg02770054,0.378187118315217,Body-island,0.364569479517687,['hsa04971:Gastric acid secretion']
347,RYR3,cg02186782,0.37756264499534,TSS1500-island,0.370417428074195,"['hsa04020:Calcium signaling pathway', 'hsa04713:Circadian entrainment', 'hsa04921:Oxytocin signaling pathway']"
348,MAML3,cg00875805,0.377183369876617,Body-island,0.360498956595312,
349,C1QTNF5,cg20483374,0.377105383527525,5'UTR-island,0.365720372940059,
350,HOXA1,cg09420439,0.376604216238605,TSS1500-island,0.367436473865753,
351,ILDR2,cg06445348,0.376436270745426,Body-island,0.36132241596948,
352,FAM19A1,cg09398550,0.376426955483756,Body-island,0.370741212993955,
353,NKX2-6,cg14428146,0.376398792820287,TSS200-island,0.370764170792711,
354,TCL1A,cg07445246,0.376294470391205,TSS200-island,0.369307399122527,['hsa04151:PI3K-Akt signaling pathway']
355,SPHKAP,cg12001304,0.37627699849063,Body-shore,0.367367746458558,
356,CSMD3,cg22052659,0.375865313744499,Body-island,0.368551617150184,
357,RALYL,cg04842146,0.375772851558606,TSS200-island,0.362323299217057,
358,C12orf23,cg10082647,0.375630409372739,TSS1500-shore,0.364023189977025,
359,POU4F1,cg08097882,0.375598434268868,5'UTR-island,0.35011046624877,
360,NES,cg06355129,0.375533573672644,1stExon-island,0.375533573672643,
361,NOTCH3,cg21514227,0.375533411754586,Body-island,0.364825441407073,"['hsa05200:Pathways in cancer', 'hsa05206:MicroRNAs in cancer']"
362,PPP2R2B,cg22642777,0.375424160539648,Body-shore,0.375424160539648,"['hsa04151:PI3K-Akt signaling pathway', 'hsa04390:Hippo signaling pathway']"
363,ACTN2,cg18770350,0.375085640695313,1stExon-island,0.35958709407641,['hsa05412:Arrhythmogenic right ventricular cardiomyopathy']
364,EEF1A2,cg26186239,0.375045505831149,3'UTR-island,0.35499143681644,
365,TMEM132D,cg12122146,0.37500975063628,TSS200-island,0.365150811349976,
366,C19orf51,cg18417954,0.374959104573097,Body-island,0.355423331450671,
367,HSPB6,cg14120049,0.374825691555149,3'UTR-island,0.365114619452213,
368,LEMD2,cg07979401,0.374788789760726,3'UTR-island,0.368862757736341,
369,TLX2,cg21185289,0.374427551243379,3'UTR-island,0.367433757299462,
370,PRDM15,cg26519184,0.374135281023858,Body-shore,0.362831907798239,
371,BMP7,cg18759209,0.373931982280481,TSS1500-shore,0.370054496887021,['hsa04390:Hippo signaling pathway']
372,DDAH2,cg17983217,0.373867656737433,TSS200-island,0.363309971089435,
373,SPTBN4,cg22498143,0.373662368154942,Body-shore,0.368893250831901,
374,FHL3,cg08423562,0.37333771270659,5'UTR-opensea,0.352831267232468,
375,CIDEA,cg07204280,0.373043988829421,Body-island,0.35954733104447,
376,CACNA1I,cg00058879,0.372917673714741,Body-island,0.370469244139088,"['hsa04020:Calcium signaling pathway', 'hsa04713:Circadian entrainment']"
377,KCNA2,cg22165175,0.372706279252275,TSS1500-shore,0.354085389037858,
378,STAT5A,cg20388732,0.372580547843071,TSS200-shore,0.363678592091846,['hsa05200:Pathways in cancer']
379,SPAG6,cg12377139,0.372520419437641,TSS200-island,0.361356369576711,
380,STMN2,cg09071889,0.372476486959242,5'UTR-shore,0.369776546385192,
381,TLX3,cg26844246,0.371970628090496,TSS200-island,0.352978593295252,['hsa05202:Transcriptional misregulation in cancer']
382,UTF1,cg09053680,0.371893780398799,1stExon-island,0.353170829696386,
383,CDH5,cg00044665,0.371705894525466,TSS200-opensea,0.361764062831487,['hsa04514:Cell adhesion molecules']
384,IRX1,cg10530883,0.371506448459789,1stExon-island,0.354682644657729,
385,TRABD,cg11213574,0.371360418201122,TSS1500-island,0.364748307040811,
386,WIT1,cg25247290,0.371352281684905,Body-shore,0.364897854158704,
387,MGAT5B,cg04946749,0.371292896126891,Body-island,0.351150275450334,
388,TSPAN32,cg00472277,0.371079738199919,Body-opensea,0.358314337321973,
389,CDO1,cg02792792,0.371007524032682,TSS200-island,0.362416810493414,
390,LOC645323,cg12393318,0.370571415744732,TSS1500-island,0.359804381897881,
391,EBF1,cg16126280,0.37042523256974,TSS1500-island,0.363902681447243,
392,XKR4,cg09388605,0.370284289647486,TSS1500-island,0.360662343137023,
393,PDIA3P,cg05774978,0.370151776476151,Body-island,0.353195686702504,
394,NAALADL1,cg15000841,0.369834030830398,Body-island,0.356605228653619,
395,FES,cg26405020,0.369003232341489,TSS1500-shore,0.366316497901722,
396,TMEM220,cg02025583,0.368872107793555,Body-island,0.354604032484398,
397,FRZB,cg04037038,0.368369372246172,TSS1500-island,0.36369141110912,
398,GALR3,cg07879739,0.368367796955078,Body-island,0.362778077871104,['hsa04080:Neuroactive ligand-receptor interaction']
399,PHOX2A,cg18722841,0.368325293725369,1stExon-island,0.35358349625923,
400,PLD5,cg00812833,0.36822383032966,5'UTR-island,0.351393171771299,
401,HAPLN4,cg22694191,0.367754336554951,5'UTR-shore,0.363667390249227,
402,TCERG1L,cg06304097,0.367661687547285,1stExon-island,0.35021888373725,
403,KCNIP4,cg06482428,0.367494799905381,5'UTR-island,0.36210515225015,
404,FLI1,cg19897940,0.367303035494176,TSS200-island,0.360239476005973,['hsa05202:Transcriptional misregulation in cancer']
405,GJD2,cg16729415,0.366941867423025,TSS1500-island,0.353401157465262,
406,HS3ST2,cg08214995,0.366690877151696,1stExon-island,0.358510626884774,
407,COL5A2,cg09211763,0.366296029976905,1stExon-opensea,0.356895953021625,
408,HOXD12,cg02694427,0.365553990397259,TSS200-island,0.360271077104608,
409,C2orf40,cg21838979,0.365407801840137,TSS200-shore,0.351458683829666,
410,HOXD11,cg11546137,0.365390982560282,1stExon-shore,0.355825961131076,
411,BHLHE23,cg26492446,0.364956671241318,TSS200-island,0.352649609061967,
412,CSMD1,cg09159022,0.364693077618651,Body-island,0.356205987782463,
413,PRR5,cg26995244,0.364611586209632,Body-island,0.354439833087645,
414,EPSTI1,cg12138678,0.364218720972493,TSS1500-shore,0.350771244473424,
415,SRGAP3,cg00907288,0.364212221359221,Body-shore,0.358691136486479,
416,CARTPT,cg08351336,0.364171347390991,TSS200-shore,0.353457659844076,
417,SYN2,cg15873301,0.363811526367979,TSS1500-shore,0.363811526367979,
418,CD38,cg26043257,0.363787123104497,1stExon-island,0.350562371184804,"['hsa04020:Calcium signaling pathway', 'hsa04921:Oxytocin signaling pathway', 'hsa04972:Pancreatic secretion']"
419,TECR,cg23690893,0.363591979892076,Body-opensea,0.354904811396614,
420,TNFAIP8L3,cg05905176,0.363579453708892,Body-island,0.353617375521145,
421,DLK1,cg02874376,0.363179788673298,1stExon-island,0.354988754039643,
422,F7,cg03338754,0.363045850105524,Body-island,0.35543281954793,
423,EVX1,cg15564098,0.362788048771654,TSS1500-shore,0.352985778409729,
424,DDIT4L,cg25071651,0.362587106412831,TSS1500-shore,0.355869894438614,
425,TCF7L1,cg07847030,0.362280229542355,Body-island,0.350233116856523,"['hsa05200:Pathways in cancer', 'hsa05225:Hepatocellular carcinoma', 'hsa04390:Hippo signaling pathway', 'hsa05412:Arrhythmogenic right ventricular cardiomyopathy']"
426,PSKH2,cg15541630,0.361479539823747,1stExon-island,0.357629989040803,
427,SHANK2,cg21202716,0.361413358605831,Body-shore,0.351610518337406,['hsa04724:Glutamatergic synapse']
428,LEPREL1,cg19046725,0.36070309664141,5'UTR-island,0.355529544268172,
429,TBX18,cg06733419,0.360351273612055,Body-island,0.351570016138914,
430,C9orf129,cg10065823,0.359627105284952,1stExon-island,0.359627105284952,
431,LIMD2,cg04918402,0.359439804355614,TSS1500-island,0.353563140846409,
432,GALNT7,cg21739530,0.359282624678475,Body-opensea,0.35475443654399,
433,SEPT9,cg02320862,0.359137346273937,5'UTR-island,0.354176796528525,
434,ADAM5P,cg14742937,0.358708778770644,TSS200-opensea,0.352530724922761,
435,PCDHA1,cg11095383,0.35858615817673,Body-island,0.354487287368667,
436,SDPR,cg08390172,0.358225697247649,5'UTR-opensea,0.350153534144401,
437,PITX1,cg00396667,0.358034389264581,3'UTR-island,0.358034389264583,
438,GEFT,cg15409097,0.357170499832056,TSS1500-island,0.357170499832057,
439,ESRRG,cg09106903,0.357151137498962,5'UTR-shore,0.350692203983512,
440,FAM19A2,cg00089798,0.357111296398164,5'UTR-island,0.35130493050499,
441,ATP6V1B1,cg04751811,0.356983953664693,3'UTR-island,0.351720011888527,
442,GRM7,cg21187352,0.356470351864182,1stExon-island,0.353055110519517,"['hsa04080:Neuroactive ligand-receptor interaction', 'hsa04724:Glutamatergic synapse', 'hsa04072:Phospholipase D signaling pathway']"
443,FOXB1,cg26517663,0.356172319591651,TSS1500-shore,0.350651464317727,
444,RAB22A,cg26029902,0.355678525229145,TSS1500-shore,0.355678525229145,
445,MARCH11,cg12456714,0.355558323827043,TSS1500-island,0.352092279495705,
446,LMOD1,cg02970525,0.355116741016763,TSS1500-opensea,0.350532620048266,
447,SLC12A5,cg06132069,0.353587554328837,Body-island,0.353587554328835,['hsa04727:GABAergic synapse']
448,SYT6,cg19901801,0.353164349575118,TSS1500-island,0.350284741980524,
449,TSSK6,cg25352836,0.350683706714661,3'UTR-island,0.351534752084646,
